Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

BACKGROUND: Despite increased atherothrombotic risk in type 2 diabetes mellitus, (T2DM) the best preventative antithrombotic strategy remains undetermined. We defined the effects of three antiplatelet agents on functional readout and biomarker kinetics in platelet activation and coagulation in patie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiovasc Diabetol
Hlavní autoři: Parker, William A. E., Schulte, Christian, Barwari, Temo, Phoenix, Fladia, Pearson, Sam M., Mayr, Manuel, Grant, Peter J., Storey, Robert F., Ajjan, Ramzi A.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945631/
https://ncbi.nlm.nih.gov/pubmed/31910903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0981-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky